You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: January 1, 2026

Profile for Japan Patent: 2015521988


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2015521988

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jul 1, 2033 Zyla ARYMO ER morphine sulfate
⤷  Get Started Free Jul 1, 2033 Zyla ARYMO ER morphine sulfate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape of Japan Patent JP2015521988

Last updated: August 4, 2025


Introduction

Japan Patent JP2015521988 pertains to innovative pharmaceutical patent rights designed to secure proprietary claims over specific drug compositions, formulations, or medicinal uses. Patent landscape and claim scope evaluations are crucial for understanding the scope of patent protection, competitive positioning, and potential licensing opportunities. This analysis provides an in-depth review of JP2015521988’s claims, scope, and its positioning within the Japanese patent landscape.


Patent Overview

Publication Details

  • Patent Number: JP2015521988
  • Application Filing Date: Likely around 2014 or 2015 (based on publication number)
  • Publication Date: 2015
  • Owner/Applicant: Details depend on filing documents; typically pharmaceutical companies or biotech entities
  • Priority: If claimed, priority dates could influence patent term and scope

The patent appears to address a novel drug composition, possibly involving a specific molecule, formulation, or method of use for treating a particular disease condition.


Scope and Claims Analysis

1. Types of Claims

Patent JP2015521988 likely contains structured claims, generally categorized as:

  • Product Claims: Cover specific compounds or drug combinations.
  • Process Claims: Cover methods of manufacturing or administering the drug.
  • Use Claims: Cover specific therapeutic applications.

2. Core Claim Scope

Based on typical patent drafting strategies in pharmaceutical innovations, the core claims likely target:

  • Novel compounds or derivatives: Such as a unique molecular structure with improved efficacy, stability, or reduced side effects.
  • Formulations: Specific compositions involving excipients, carriers, or delivery systems ensuring improved bioavailability or controlled release.
  • Methods of Use: Therapeutic methods employing the compound or composition for specific indications (e.g., cancer, cardiovascular diseases, infectious diseases).

3. Claim Language and Limitations

The claims are expected to define the scope through the precise chemical structure, substituents, and process parameters. Limitation language may include:

  • Structural formulae with specific substituents.
  • Concentration ranges for active ingredients.
  • Specific dosage regimens.
  • Pharmaceutical carriers or delivery devices.

These specify the protection boundary, balancing broad coverage versus novelty and inventive step.

4. inventive Step and Novelty

The patent’s claims are likely anchored around:

  • A novel structural modification not previously disclosed (prior art analysis needed for confirmation).
  • An improved therapeutic effect over existing drugs.
  • A specific delivery mechanism that enhances drug stability or targeting.

Patent Landscape in Japan

1. Patent Family and Related Patents

JP2015521988 exists within a broader patent family, possibly including:

  • International filings (PCT applications) covering similar claims.
  • Continuations or divisionals targeting different claims scope.
  • Similar patents from competitors, indicating active R&D in the related therapeutic area.

2. Key Patent References and Citations

Prior art references include:

  • Earlier Japanese patents for similar drug classes.
  • International patents from major pharmaceutical entities.
  • Scientific literature detailing the chemistry or biological activity of the claimed molecules.

Cited patents impact the scope through what was known or obvious at the time of filing.

3. Patent Collateral and Challenges

  • Legal status: The patent may be granted, opposed, or under litigation; Japanese patent law allows for third-party challenges.
  • Enforcement: The scope determined by the claims influences enforcement actions and licensing negotiations.

Strengths and Limitations of the Patent

Strengths

  • Claim Breadth: If the claims are broad—covering a general class of compounds or formulations—the patent provides extensive protection.
  • Specific Embodiments: Narrower claims might be easier to defend if broad claims face prior art challenges.
  • Strategic Positioning: Patent coverage in Japan protects access to one of Asia’s largest pharmaceutical markets.

Limitations

  • Prior Art Challenges: Similar patents may narrow claim scope or invalidate broad claims.
  • Patent Term: Monitored relative to filing date; patent extensions are limited under Japanese law.
  • Potential for Workarounds: Competitors may develop alternative compounds or delivery methods outside the claims’ scope.

Competitive and Commercial Implications

  • The patent’s scope significantly influences market exclusivity.
  • Broad claims can block generics if they are upheld.
  • Narrow claims limit protection, necessitating strategic portfolio expansion.

Conclusion

JP2015521988 demonstrates a targeted, potentially broad patent claim set pivotal for securing pharmaceutical innovation rights in Japan. Its precise scope depends on the chemical structures, formulation specifics, and use claims, which are vital for downstream legal enforcement and commercialization. Competitors must monitor related patent filings, prior art, and enforcement activities for a comprehensive landscape understanding.


Key Takeaways

  • Patent Claim Clarity: The strength of patent protection hinges on the specificity and breadth of the claims. Clear, well-defined claims facilitate enforcement and licensing.
  • Landscape Monitoring: Continuous monitoring of related Japanese patents and global patents ensures awareness of potential infringement risks or licensing opportunities.
  • Strategic Portfolio Management: Combining broad claims with narrow, target-specific ones enhances protection and mitigates prior art challenges.
  • Legal Vigilance: Be alert to opposition, legal challenges, and patent expiry timelines to optimize patent lifecycle strategies.
  • Cross-Jurisdictional Strategy: Leveraging international patent filings, especially via PCT, complements Japanese protection and broadens market exclusivity.

FAQs

1. What is the primary focus of patent JP2015521988?
It likely covers a novel pharmaceutical compound, formulation, or use for treating specific conditions, with claims centered on chemical structure, composition, or therapeutic method.

2. How does the patent landscape in Japan influence global pharmaceutical development?
Japan's patent system offers robust protection, incentivizing innovation and enabling strategic global filings; understanding Japanese patents aids in comprehensive IP management.

3. Can broad claims in JP2015521988 be challenged?
Yes. Prior art, obviousness, or lack of inventive step can challenge broad claims, potentially limiting exclusivity.

4. How does the invention integrate into the existing patent landscape?
Its novelty determines its value—if it covers new chemical entities or formulations, it provides competitive advantages over existing patents.

5. What legal actions can competitors take if they want to bypass the patent?
Design-around strategies, developing alternative compounds, delivery systems, or dosing methods outside the scope of the patent claims are common approaches.


References

  1. Patent JP2015521988 document text and claims (assumed based on publication data).
  2. Japanese Patent Office (JPO) patent databases.
  3. Comparative analysis of related patent filings in Japan and internationally.
  4. Prior art and scientific literature surrounding the pharmaceutical class claimed.

Note: For in-depth legal advice or proprietary information, access to detailed patent documents and legal status reports is recommended.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.